Elucidating the mechanism by which A1AT is taken up and secreted by lung endothelial cells may provide useful targets of therapeutic intervention that can improve A1AT uptake and deliver effective lung concentrations in AATD patients. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.